Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

European Group For Research In Schizophrenia

Clinical trials sponsored by European Group For Research In Schizophrenia, explained in plain language.

Trials to join now! 1

New schizophrenia drug aims to sharpen minds in Year-Long trial

Disease control Recruiting now

This study is testing whether a newer schizophrenia medication, Xanomeline/Trospium (XT), can improve thinking, memory, and concentration over one year of treatment. It will involve about 171 adults with schizophrenia who are already on stable medication. The main goal is to see …

Phase: PHASE3 • Sponsor: European Group for Research In Schizophrenia • Aim: Disease control

Last updated Apr 02, 2026 14:57 UTC